Shared by
beno
Fundamentals
As of: Sep 30 2019 Q (Share outstanding is latest)
Shares Outstanding (latest from broker): 42.6m
Cash: 71.167m (+$250m from recent offerings)
Current liabilities: 21.575m
Current ratio: 4.2
NWC (total current assets - total current liabilities): 67.5m
Accumulated deficit: 1.4b (WOW THIS IS HUGE)
Book value per share (Stock holder equity / Shares outstanding): -6.08
Monthly Burn rate (net cash used in operating activities / months): 12.54m
Estimated current cash: 258.467m (with cash from offerings)
Catalysts / News / Painting the picture
Sympathy play on China Corona Virus outbreak
Begins animal testing for COVID-19 vaccine
$250m shelf on Dec 31 2019 (All used from below prospectuses)
Jan 21 2020: $100m ATM
Mar 02 2020: $150m ATM
Enough cash for 20 months if counting cash from above offerings
April 08 2020: Identifies COVID-19 Vaccine Candidate, Human Testing To Begin In Mid-May
Technical Analysis
-Intraday pattern: Runner
-Levels: 17.8, 18.5, 19, 19.3, 19.8
Original Plan / Strategy
First test long of 18.8 level, no confluence
Review
No confluence and low volume so only took setup with two lots, took 10 cents on one lot and had to scratch the other lot because the trade wasn't working after that 10 cent bounce.
Execution detail:
| Date/time | Symbol | Side | Price | Position |
|---|---|---|---|---|
| 2020-04-17 12:47:50 | NVAX | buy | $18.870 | long |
| 2020-04-17 12:47:50 | NVAX | buy | $18.870 | long |
| 2020-04-17 12:47:52 | NVAX | buy | $18.870 | long |
| 2020-04-17 12:48:17 | NVAX | buy | $18.907 | long |
| 2020-04-17 12:48:17 | NVAX | buy | $18.905 | long |
| 2020-04-17 12:50:55 | NVAX | sell | $18.970 | long |
| 2020-04-17 12:53:05 | NVAX | sell | $18.900 | long |
| 2020-04-17 12:53:05 | NVAX | sell | $18.902 | long |
| 2020-04-17 12:53:05 | NVAX | sell | $18.904 | 0 |
Leave a comment about this trade!
You need to log into your Tradervue account to leave a comment. If you don't have one,
it takes
just a few seconds to sign up, and it's free!